Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
BMC Cancer|June 28, 2008
ADAM9 is highly expressed in renal cell cancer and is associated with tumour progressionFlorian R Fritzsche, Kirsten Wassermann, Monika Jung, et al.
European Urology|May 3, 2008
Identification of stanniocalcin 2 as prognostic marker in renal cell carcinomaHellmuth-A Meyer, Angelika Tölle, Monika Jung, et al.
International Journal of Cancer|November 25, 2010
Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynxGerhard Frank Huber, Florian R Fritzsche, Lena Züllig, et al.
British Journal of Cancer|September 11, 2008
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnosticsG Kristiansen, F R Fritzsche, K Wassermann, et al.
Plos One|November 6, 2015
A Mutual Self- and Informant-Report of Cognitive Complaint Correlates with Neuropathological Outcomes in Mild Cognitive ImpairmentKatherine A Gifford, Dandan Liu, Timothy J Hohman, et al.
British Journal of Cancer|January 24, 2008
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomyW Weichert, A Röske, V Gekeler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2010
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohortRaquel Esgueva, Sven Perner, Christopher J LaFargue, et al.
BMC Cancer|December 23, 2008
Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancerFlorian R Fritzsche, Wilko Weichert, Annika Röske, et al.
Histopathology|May 13, 2010
Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomasMarc-Oliver Riener, Florian R Fritzsche, Christopher Soll, et al.
European Urology|December 7, 2007
ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancerFlorian R Fritzsche, Monika Jung, Angelika Tölle, et al.
Pageof 5